790PD - Safety and immunogenicity of a DNA-vaccine immunotherapy in men with biochemically (PSA) relapsed prostate cancer

Autor: Shore, N.D., Heath, E., Nordquist, L., Cheng, H., Bhatt, K., Morrow, M., McMullan, T., Kraynyak, K., Lee, J., Sacchetta, B., Liu, L., Rosencranz, S., Tagawa, S.T., Parikh, R.A., Tutrone, R., Garcia, J., Whang, Y., Kelly, W., Csiki, I., Bagarazzi, M.
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v272-v272
Databáze: ScienceDirect